CG
ORGO icon

Caprock Group’s Organogenesis Holdings ORGO Stock Holding History

Caprock Group’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$51.5K Buy
+11,919
New +$48.1K ﹤0.01% 1054

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caprock Group's ORGO Position: Q1 2025 in Review

Caprock Group opened a new position in Organogenesis Holdings (ORGO) in Q1 2025: 11,919 shares worth $51.5K. The stake represents ﹤0.01% of the portfolio and ranks #1054 among its holdings.

136 funds tracked by Wall St. Rank hold ORGO as of Q1 2025.

  • Caprock Group held 11,919 shares of Organogenesis Holdings worth $51.5K as of Q1 2025.
  • Organogenesis Holdings was a new Caprock Group position in Q1 2025.
  • Organogenesis Holdings made up ﹤0.01% of Caprock Group's portfolio in Q1 2025, its #1054 holding.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2025.

Based on Caprock Group's 13F filing for Q1 2025, filed 15 May 2025.